🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT06998771
Treatments Being Tested
This study is designed to compare the efficacy and safety of KN026 combined...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-30
Trial ID
NCT07332533
Treatments Being Tested
This is an open-lable, multicenter, and single arm phase II trial to evalua...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2021-08-09
Trial ID
NCT04881929
Treatments Being Tested
This is a multicenter II study to compare KN026 and KN046 versus Oxaliplati...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-09-22
Trial ID
NCT06023758
This is an open-label, three-cohort phase 2 study of KN026 in subjects with...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2019-12-31
Trial ID
NCT04165993
Treatments Being Tested
This is a randomized, controlled, open-label, multicenter, phase Ш clinical...
Status
Recruiting
Location
Clinical Trials Information Group
Start Date
2023-07-23
Trial ID
NCT05838066
This is a randomized, controlled, open-label, multicenter, Phase Ⅲ clinical...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-06
Trial ID
NCT07441460
Treatments Being Tested
This is a phase Ib, open-label, dose-escalation and expansion study to eval...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2019-09-26
Trial ID
NCT04040699
Treatments Being Tested
This randomized, controlled, open-label, multicenter study will evaluate th...
Status
Active Not Recruiting
Location
Clinical Trials Information Group
Start Date
2024-12-16
Trial ID
NCT06747338
Treatments Being Tested
This is an open-label, multicenter, dose-escalation and parallel-group expa...
Status
Terminated
Location
Fudan University Shanghai Cancer Center
Start Date
2022-05-25
Trial ID
NCT04778982
Treatments Being Tested